These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 19840866)

  • 1. Visualizing the drug target landscape.
    Campbell SJ; Gaulton A; Marshall J; Bichko D; Martin S; Brouwer C; Harland L
    Drug Discov Today; 2010 Jan; 15(1-2):3-15. PubMed ID: 19840866
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Visualizing the drug target landscape.
    Campbell SJ; Gaulton A; Marshall J; Bichko D; Martin S; Brouwer C; Harland L
    Drug Discov Today; 2012 Feb; 17 Suppl():S3-15. PubMed ID: 22178891
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Development of antituberculous drugs: current status and future prospects].
    Tomioka H; Namba K
    Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mining and visualizing the chemical content of large databases.
    Villar HO; Hansen MR
    Curr Opin Drug Discov Devel; 2009 May; 12(3):367-75. PubMed ID: 19396738
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Literature mining, ontologies and information visualization for drug repurposing.
    Andronis C; Sharma A; Virvilis V; Deftereos S; Persidis A
    Brief Bioinform; 2011 Jul; 12(4):357-68. PubMed ID: 21712342
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mining small-molecule screens to repurpose drugs.
    Swamidass SJ
    Brief Bioinform; 2011 Jul; 12(4):327-35. PubMed ID: 21715466
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Target discovery from data mining approaches.
    Yang Y; Adelstein SJ; Kassis AI
    Drug Discov Today; 2009 Feb; 14(3-4):147-54. PubMed ID: 19135549
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Alternative strategies in drug development: clinical pharmacological aspects.
    Kuhlmann J
    Int J Clin Pharmacol Ther; 1999 Dec; 37(12):575-83. PubMed ID: 10599949
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Data is the currency of R&D, and that currency is now generated and traded globally.
    Brown FK; Maliski E; Waller C
    Curr Opin Drug Discov Devel; 2010 May; 13(3):275-8. PubMed ID: 20464800
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Drug target central.
    Harland L; Gaulton A
    Expert Opin Drug Discov; 2009 Aug; 4(8):857-72. PubMed ID: 23496271
    [TBL] [Abstract][Full Text] [Related]  

  • 11. G-protein-coupled receptor-focused drug discovery using a target class platform approach.
    Heilker R; Wolff M; Tautermann CS; Bieler M
    Drug Discov Today; 2009 Mar; 14(5-6):231-40. PubMed ID: 19121411
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Risk management frameworks for human health and environmental risks.
    Jardine C; Hrudey S; Shortreed J; Craig L; Krewski D; Furgal C; McColl S
    J Toxicol Environ Health B Crit Rev; 2003; 6(6):569-720. PubMed ID: 14698953
    [TBL] [Abstract][Full Text] [Related]  

  • 13. New approaches to drug discovery and development: a mechanism-based approach to pharmaceutical research and its application to BNP7787, a novel chemoprotective agent.
    Hausheer FH; Kochat H; Parker AR; Ding D; Yao S; Hamilton SE; Petluru PN; Leverett BD; Bain SH; Saxe JD
    Cancer Chemother Pharmacol; 2003 Jul; 52 Suppl 1():S3-15. PubMed ID: 12819940
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chemogenomics approaches to novel target discovery.
    Gaither LA
    Expert Rev Proteomics; 2007 Jun; 4(3):411-9. PubMed ID: 17552925
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical data mining and research in the allergy office.
    Dalan D
    Curr Opin Allergy Clin Immunol; 2010 Jun; 10(3):171-7. PubMed ID: 20179584
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Biomarkers: "Found in translation"].
    Lockhart BP; Walther B
    Med Sci (Paris); 2009 Apr; 25(4):423-30. PubMed ID: 19409197
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Improving drug discovery with contextual assays and cellular systems analysis.
    Westwick JK; Lamerdin JE
    Methods Mol Biol; 2011; 756():61-73. PubMed ID: 21870220
    [TBL] [Abstract][Full Text] [Related]  

  • 18. What makes a good drug target?
    Gashaw I; Ellinghaus P; Sommer A; Asadullah K
    Drug Discov Today; 2011 Dec; 16(23-24):1037-43. PubMed ID: 21945861
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Towards a more robust approach to selecting and prosecuting promising targets and compounds.
    Robertson G
    Future Med Chem; 2010 Jan; 2(1):25-34. PubMed ID: 21426044
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Towards quantitative biology: integration of biological information to elucidate disease pathways and to guide drug discovery.
    Fischer HP
    Biotechnol Annu Rev; 2005; 11():1-68. PubMed ID: 16216773
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.